Skip to content

Anxiety: all studies

Page 226 of 769: studies 2,251 to 2,260 of 7,689, newest first. Back to the anxiety overview

Research

Mindfulness-based stress reduction combined with early cardiac rehabilitation improves negative mood states and cardiac function in patients with acute myocardial infarction assisted with an intra-aortic balloon pump: a randomized controlled trial

Frontiers in Cardiovascular Medicine May 31, 2023 Kemei Wu, Miaomiao Wan, Huiqin Zhou et al.

ObjectiveTo investigate the clinical effects of mindfulness-based stress reduction (MBSR) intervention combined with early cardiac rehabilitation (CR) on patients with acute myocardial infarction (AMI) assisted with an intra-aortic balloon pump (IABP).MethodsA total of 100 AMI patients with IABP assistance due to hemodynamic instability at Wuhan Asia Heart Hospital were enrolled in the study....

Effectiveness of mindfulness-based interventions on mental, cognitive outcomes and neuroplastic changes in older adults with mild cognitive impairment: A systematic review and meta-analysis.

Journal of Advanced Nursing May 29, 2023 Yihong Leow, Nur Lidiya Binte Abdul Rashid, Piyanee Klainin‐Yobas et al.

Aims: To evaluate the effectiveness of mindfulness-based interventions (MBIs) on mental and cognitive outcomes including, anxiety, depression, attention, memory, global cognition and neuroplastic changes in older adults with mild cognitive impairment (MCI). Design: Systematic review and meta-analysis. Data source: A three-step search strategy was conducted on eight electronic databases, grey...

Psychedelics: Threshold of a Therapeutic Revolution

Neuropharmacology May 27, 2023 David J Heal, Sharon L. Smith, Sean J Belouin et al. 50 citations

This Special Issue of Neuropharmacology on psychedelics provides a timely and comprehensive update on progress following the previous Neuropharmacology Special Issue "Psychedelics: New Doors, Altered Perceptions". Remarkable advances have been made in basic and clinical research on psychedelics in the five years since 2018. It is partly based on the seminar series focused on psilocybin...

Editorial: Mindfulness in Schools: Promises, Challenges, and Future Directions.

Journal of the American Academy of Child & Adolescent Psychiatry May 26, 2023 J Corey Williams, Janaíre Hawkins

Amid rising national rates of childhood depression and anxiety,1,2 the development and accessibility of therapeutic psychosocial interventions for children have taken on paramount importance. Given the limited bandwidth of the existing clinical mental health services nationally, there is also an imperative to integrate therapeutic interventions within nonclinical, community-based settings (eg,...

Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders.

International Journal of Molecular Sciences May 20, 2023 Małgorzata Frankowska, Karolina Wydra, Agata Suder et al.

The lack of selective pharmacological tools has limited the full unraveling of G protein-coupled receptor 18 (GPR18) functions. The present study was aimed at discovering the activities of three novel preferential or selective GPR18 ligands, one agonist (PSB-KK-1415) and two antagonists (PSB-CB-5 and PSB-CB-27). We investigated these ligands in several screening tests, considering the...

THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE

PARIPEX INDIAN JOURNAL OF RESEARCH May 15, 2023 Chirag Ambaliya, Dimple Gupta, Ashok Vala et al.

The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD,...

Exploring the Links Between Dream Experience, Nightmares, Sleep-Related Disturbances, and Subjective Well-Being

American Journal of Applied Psychology May 10, 2023 Ornella Montebarocci, Paola Surcinelli, Sara Giovagnoli 1 citation

The purpose of this study was to investigate the relationship between the subjective experience of dreams, anxiety, and depressive symptoms. Specifically, the study aimed to explore whether the subjective experience of dreams, including how often dreams are remembered, the presence of nightmares, and the way in which a person thinks about dreams, could influence the occurrence of subjective...

A Retrospective Study to Determine the Impact of Psychedelic Therapy for Dimensional Measures of Wellness: A Quantitative Analysis

medRxiv May 10, 2023 Victoria di Virgilio, Amir Minerbi, Jagpaul Kaur Deol et al. preprint

Abstract Background The World Health Organization (WHO) defines wellness as the optimal state of health of individuals and groups. No study to date has identified the impact of psychedelic medicines on optimizing wellness using a dimensional approach. Using this approach, treatment effects can be measured more broadly using a composite score of participants’ global perceptions of change for...

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey

Medicina May 9, 2023 Gniewko Więckiewicz, Julia Marek, Iga Stokłosa et al. 5 citations

Background and Objectives: PolDrugs is the largest Polish naturalistic nationwide survey to present basic demographic and epidemiological data that could potentially prevent harm from illicit substances intake in drugs users. The most recent results were presented in 2021. The goal of this year’s edition was to re-present the above data and compare it to the previous edition’s data to identify...

Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant

Health and Quality of Life Outcomes May 8, 2023 Carol Jamieson, Vanina Popova, Ella Daly et al. 18 citations

BACKGROUND: Patients with treatment-resistant depression (TRD) report significant deficits in physical and mental health, as well as severely impaired health-related quality of life (HRQoL) and functioning. Esketamine effectively enhances the daily functioning in these patients while also improving their depressive symptoms. This study assessed HRQoL and health status of patients with TRD, who...